Evidence map›Paper›PMID 31882972›Full record

ArticleScientific reports2019

Stepped vitrification technique for human ovarian tissue cryopreservation.

Ellen Cristina Rivas Leonel, Ariadna Corral, Ramon Risco, Alessandra Camboni, Sebastião Roberto Taboga, Peter Kilbride, Marina Vazquez, John Morris, Marie-Madeleine Dolmans, Christiani A Amorim

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Ellen Cristina Rivas LeonelPôle de Recherche en Gynécologie, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Avenue Mounier 52, bte B1.52.02, 1200, Brussels, Belgium.ORCID http://orcid.org/0000-0002-4597-3346
Ariadna CorralCentro Nacional de Aceleradores (CNA), University of Seville, Calle Thomas Alva Edison 7, 41092, Seville, Spain.
Ramon RiscoCentro Nacional de Aceleradores (CNA), University of Seville, Calle Thomas Alva Edison 7, 41092, Seville, Spain.
Alessandra CamboniPôle de Recherche en Gynécologie, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Avenue Mounier 52, bte B1.52.02, 1200, Brussels, Belgium.
Sebastião Roberto TabogaDepartament of Biology, Institute of Biosciences, Humanities and Exact Sciences, São Paulo State University (UNESP), Rua Cristóvão Colombo, 2265, Jardim Nazareth, 15054-000, São José do Rio Preto, Brazil.ORCID http://orcid.org/0000-0002-0970-4288
Peter KilbrideGeneral Electric Healthcare, Sovereign House, Vision Park, Cambridge, CB24 9BY, United Kingdom.
Marina VazquezEngineering School of Sevilla, University of Seville, Camino Descubrimientos S/N, Isla Cartuja, 41092, Seville, Spain.
John MorrisGeneral Electric Healthcare, Sovereign House, Vision Park, Cambridge, CB24 9BY, United Kingdom.
Marie-Madeleine DolmansPôle de Recherche en Gynécologie, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Avenue Mounier 52, bte B1.52.02, 1200, Brussels, Belgium.
Christiani A AmorimPôle de Recherche en Gynécologie, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Avenue Mounier 52, bte B1.52.02, 1200, Brussels, Belgium. christiani.amorim@uclouvain.be.ORCID http://orcid.org/0000-0003-1794-0368
General Electric (United Kingdom) · GBCentro Nacional de Aceleradores · ESCliniques Universitaires Saint-Luc · BEUniversidade Estadual Paulista (Unesp) · BRUCLouvain · BE

Funding

MONOCLONAL ANTIBODIS TO TESTICULAR GERM CELL TUMORSF05TW004150 · FIC · DUKE UNIVERSITY · PI YAMAZAKI, HARUKI · 1988 to 1989
–
6 · The paper itself

Abstract

The advantage of stepped vitrification (SV) is avoiding ice crystal nucleation, while decreasing the toxic effects of high cryoprotectant concentrations. We aimed to test this method for human ovarian tissue cryopreservation. Ovarian cortex was taken from 7 fertile adult women. Samples were subjected to an SV protocol performed in an automatic freezer, which allowed sample transfer to ever higher concentrations of dimethyl sulfoxide (DMSO) as the temperature was reduced. Histological evaluation of the vitrified-warmed tissue showed large numbers of degenerated follicles after 24 hours of in vitro culture. We therefore evaluated DMSO perfusion rates by X-ray computed tomography, ice crystal formation by freeze-substitution, and cell toxicity by transmission electron microscopy, seeking possible reasons why follicles degenerated. Although cryoprotectant perfusion was considered normal and no ice crystals were formed in the tissue, ultrastructural analysis detected typical signs of DMSO toxicity, such as mitochondria degeneration, alterations in chromatin condensation, cell vacuolization and extracellular matrix swelling in both stromal and follicular cells. The findings indicated that the method failed to preserve follicles due to the high concentrations of DMSO used. However, adaptations can be made to avoid toxicity to follicles caused by elevated levels of cryoprotectants.

Indexed as

VitrificationAdultCryopreservationCryoprotective AgentsDimethyl SulfoxideFemaleHumansOvarian FollicleCryoprotective AgentsDimethyl Sulfoxide

Identifiers

PMID31882972
PMCPMC6934833
OpenAlexW2998613145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.